Related article in
-
ArticleSeptember 30, 1995
0
260
149
A Case of Idiopathic Thrombocytopenic Purpura in HIV-infected Hemophiliac
Jong Weon Choi, Jin Tae Suh, Yong Mook Choi
Korean J Hematol 1995; 30(3): 479-485 -
Original ArticleDecember 31, 2014
3
1939
586
Progress of
in vitro factor VIII coagulant activity from 0 to 8 hours after reconstitutionYe Jee Shim, Kun Soo Lee, Uk Hyun Kim, Jin Kyung Suh, Sae Yun Baik, and Shin Young Hyun
Blood Res 2014; 49(4): 265-269 -
Original ArticleDecember 31, 2015
7
2536
631
Immune tolerance induction in patients with severe hemophilia A with inhibitors
Ji Eun Ryu, Young Shil Park, Ki Young Yoo, Kyoo Duck Lee, and Yong-Mook Choi
Blood Res 2015; 50(4): 248-253 -
Original ArticleJune 25, 2015
4
2338
531
Human coagulation factor VIII domain-specific recombinant polypeptide expression
Su Jin Choi, Ki Jung Jang, Jeong-A Lim, and Hye Sun Kim
Blood Res 2015; 50(2): 103-108 -
Case ReportMarch 31, 2012
8
738
126
A patient with acquired hemophilia A induced by clopidogrel
Hye Won Hwang, Jee Hyun Kong, Dong Wook Yu, Woo Taek Kim, Hyun Soo Kim, and Chong In Lee
Korean J Hematol 2012; 47(1): 80-82 -
Original ArticleMarch 31, 2016
4
2016
527
Long-term course of anti-factor VIII antibody in patients with hemophilia A at a single center
Ki Young Yoo, Sang Chun Joo, and Yong Mook Choi
Blood Res 2016; 51(1): 37-43 -
Original ArticleMarch 31, 2018
3
3655
797
Global hemostatic assay of different target procoagulant activities of factor VIII and factor IX
Ki-Young Yoo, Soo-Young Jung, Sung-Ho Hwang, Su-Min Lee, Jong-Ho Park, and Hyun-Ja Nam
Blood Res 2018; 53(1): 41-48 -
Original ArticleSeptember 30, 2019
9
3808
1224
The prevalence and risk factors of inhibitor development of FVIII in previously treated patients with hemophilia A
Ju Young Kim, Chur Woo You
Blood Res 2019; 54(3): 204-209 -
Original ArticleSeptember 30, 2021
2
2557
471
Clinical Analysis of Hospitalized Patients with Hemophilia A: Single-hemophilia Treatment Center Experience in Korea over 10 years
Ju Young Kim, Se Jin Park, Chur Woo You
Blood Res 2021; 56(3): 141-149 -
Original ArticleDecember 31, 2022
1
1522
458
FVIII inhibitor surveillance in children with hemophilia A in Indonesia: a report from the Indonesian Pediatric Hematology-Oncology Working Group
Novie A. Chozie, Djajadiman Gatot, Bambang Sudarmanto, Susi Susanah, Rini Purnamasari, Pudjo Hagung Widjajanto, Susanto Nugroho, Olga Rasiyanti, Dian Puspitasari, Muhammad Riza, Maria C. Shanty Larasati, Sri Suryo Adiyanti, Made Citra Saraswati, Fitri Primacakti, on behalf of the Pediatric Hematology-Oncology Working Group of the Indonesian Pediatric Society
Blood Res 2022; 57(4): 272-277 -
RESEARCHMay 14, 2024
0
397
42
Assessment of the phenotypic severity of hemophilia A: using rotational thromboelastometry (ROTEM) and APTT-clot waveform analysis
Deepika Gupta, Vandana Arya, Jasmita Dass, Nitin Gupta, Manas Kalra, Anupam Sachdeva and Jyoti Kotwal
Blood Res (2024) 59:19 -
RESEARCHAugust 29, 2024
0
100
11
Evaluation of FVIII pharmacokinetic profiles in Korean hemophilia A patients assessed with myPKFiT: a retrospective chart review
Young-Shil Park
Blood Res (2024) 59:29
, Ki-Young Yoo , Sang Kyu Park , Taiju Hwang , Aeran Jung and Eun Jin Choi
Most KeyWord
?
What is Most Keyword?
- It is most registrated keyword in articles at this journal during for 2 years.
Most Read
-
Management of immune thrombocytopenia: 2022 update of Korean experts recommendations
Young Hoon Park, Dae-Young Kim, Seongkoo Kim, Young Bae Choi, Dong-Yeop Shin, Jin Seok Kim, Won Sik Lee, Yeung-Chul Mun, Jun Ho Jang, Jong Wook Lee, Hoon Kook, on behalf of Korean Aplastic Anemia Working Party
Blood Res 2022;57: 20-28 -
Diagnosis and management of thrombocytopenia in pregnancy
Young Hoon Park
Blood Res 2022;57: S79-S85
Most Cited
-
FLT3 mutations in acute myeloid leukemia: a review focusing on clinically applicable drugs
Jae-Sook Ahn, Hyeoung-Joon Kim
Blood Res 2022;57: S32-S36 -
Overview of inherited bone marrow failure syndromes
Meerim Park
Blood Res 2022;57: S49-S54
Editorial Office
+82-2-516-6582
